DK3773735T3 - Konjugat af cytotoksisk lægemiddel og prodrugform af konjugatet - Google Patents

Konjugat af cytotoksisk lægemiddel og prodrugform af konjugatet Download PDF

Info

Publication number
DK3773735T3
DK3773735T3 DK19713507.2T DK19713507T DK3773735T3 DK 3773735 T3 DK3773735 T3 DK 3773735T3 DK 19713507 T DK19713507 T DK 19713507T DK 3773735 T3 DK3773735 T3 DK 3773735T3
Authority
DK
Denmark
Prior art keywords
conjugate
cytotoxic drug
producer
producer form
cytotoxic
Prior art date
Application number
DK19713507.2T
Other languages
English (en)
Inventor
Oleksandr Koniev
Sergii Kolodych
Jean-Yves Bonnefoy
Original Assignee
Syndivia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syndivia filed Critical Syndivia
Application granted granted Critical
Publication of DK3773735T3 publication Critical patent/DK3773735T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
    • A61K47/67—Enzyme prodrug therapy, e.g. gene directed enzyme drug therapy [GDEPT] or VDEPT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
DK19713507.2T 2018-04-03 2019-04-02 Konjugat af cytotoksisk lægemiddel og prodrugform af konjugatet DK3773735T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18305390 2018-04-03
PCT/EP2019/058226 WO2019192979A1 (en) 2018-04-03 2019-04-02 Conjugate of cytotoxic drug and prodrug form of said conjugate

Publications (1)

Publication Number Publication Date
DK3773735T3 true DK3773735T3 (da) 2024-10-21

Family

ID=61965888

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19713507.2T DK3773735T3 (da) 2018-04-03 2019-04-02 Konjugat af cytotoksisk lægemiddel og prodrugform af konjugatet

Country Status (22)

Country Link
US (1) US20210023113A1 (da)
EP (1) EP3773735B1 (da)
JP (1) JP7397058B2 (da)
KR (2) KR20250117704A (da)
CN (2) CN120078904A (da)
AU (1) AU2019248589B2 (da)
CA (1) CA3095146A1 (da)
DK (1) DK3773735T3 (da)
EA (1) EA202092361A1 (da)
ES (1) ES2989309T3 (da)
FI (1) FI3773735T3 (da)
HR (1) HRP20241363T1 (da)
HU (1) HUE068574T2 (da)
IL (1) IL277693B2 (da)
LT (1) LT3773735T (da)
MX (1) MX2020010201A (da)
PL (1) PL3773735T3 (da)
PT (1) PT3773735T (da)
RS (1) RS66033B1 (da)
SI (1) SI3773735T1 (da)
SM (1) SMT202400404T1 (da)
WO (1) WO2019192979A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114437151B (zh) * 2020-11-03 2023-12-01 华东师范大学 白蛋白结合型喜树碱衍生物前药及其制备方法与应用
FR3126982B1 (fr) * 2021-09-14 2023-09-15 Centre Nat Rech Scient Vecteurs ciblant la beta-d-n-acetylglucosaminidase
CN114085256B (zh) * 2021-11-23 2024-03-19 江南大学 一种β-半乳糖苷酶响应的糖类衍生物及其应用
CN114957356B (zh) * 2022-06-17 2024-10-01 江南大学 一种β-葡萄糖醛酸酶响应的糖类衍生物及其制备方法与应用
CN120936385A (zh) 2023-03-13 2025-11-11 海德堡医药研究有限责任公司 用于在癌症治疗中使用的皮下施用的抗体-药物缀合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2960153B1 (fr) 2010-05-20 2012-08-17 Centre Nat Rech Scient Nouveaux bras autoreactifs et prodrogues les comprenant
ES2698976T3 (es) 2013-11-04 2019-02-06 Inst Nat Sante Rech Med Anticuerpo sintético de un solo dominio
FR3017298B1 (fr) 2014-02-07 2016-03-04 Centre Nat Rech Scient Conjugues et pro-drogues pour le traitement du cancer et de maladies inflammatoires

Also Published As

Publication number Publication date
KR102840665B1 (ko) 2025-07-30
EP3773735A1 (en) 2021-02-17
EP3773735B1 (en) 2024-07-10
AU2019248589B2 (en) 2025-10-23
KR20250117704A (ko) 2025-08-05
SI3773735T1 (sl) 2025-03-31
FI3773735T3 (fi) 2024-10-14
PL3773735T3 (pl) 2025-01-20
JP7397058B2 (ja) 2023-12-12
CN112004556A (zh) 2020-11-27
US20210023113A1 (en) 2021-01-28
WO2019192979A1 (en) 2019-10-10
HRP20241363T1 (hr) 2024-12-20
IL277693A (en) 2020-11-30
AU2019248589A1 (en) 2020-10-22
HUE068574T2 (hu) 2025-01-28
MX2020010201A (es) 2020-12-10
IL277693B1 (en) 2023-10-01
IL277693B2 (en) 2024-02-01
JP2021520409A (ja) 2021-08-19
LT3773735T (lt) 2024-10-25
RS66033B1 (sr) 2024-11-29
EA202092361A1 (ru) 2021-02-02
CA3095146A1 (en) 2019-10-10
SMT202400404T1 (it) 2024-11-15
KR20210018208A (ko) 2021-02-17
PT3773735T (pt) 2024-10-10
ES2989309T3 (es) 2024-11-26
CN120078904A (zh) 2025-06-03

Similar Documents

Publication Publication Date Title
IL272304A (en) Bcma monoclonal antibody-drug conjugate
IL283134A (en) Alcohol-resistant drug formulations
DK3773735T3 (da) Konjugat af cytotoksisk lægemiddel og prodrugform af konjugatet
EP3572428A4 (en) ANTI-BODY ANTI-GPR20 AND ANTI-BODY-DRUG CONJUGATE ANTI-GPR20
DK3626825T3 (da) Anti-cdh6-antistof og anti-cdh6-antistof-lægemiddelkonjugat
SG11202011159QA (en) Anti-mesothelin antibody and antibody drug conjugate thereof
MA52662A (fr) Conjugués d'il-2
DK3565550T3 (da) Farmaceutiske sammensætninger omfattende meloxicam og rizatriptan
HUE054726T2 (hu) Eribulinalapú antitest-gyógyszer konjugátumok és alkalmazási eljárások
DK3402499T3 (da) Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes
DK3352584T3 (da) Sammensætninger og fremgangsmåder til syntese af 5'-rna¿er med kappe
EP3604311A4 (en) PYRROLOBENZODIAZEPINE DIMERIC PRECURSOR AND ASSOCIATED LIGAND-BOND CONJUGATE COMPOUND
IL284007A (en) Rifamycin analogs and antibody-drug conjugates thereof
IL286483A (en) Claudin-6 antibodies and drug conjugates
DK3870234T3 (da) Antistoflægemiddelkonjugater omfattende ecteinascidinderivater
DK3773738T3 (da) Antistof-lægemiddelkonjugater og anvendelser deraf til behandling af cancer
EP3612567C0 (en) ANTI-VTCN1 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
EP3448417A4 (en) INSULIN Dimer incretin CONJUGATES
DK3765525T3 (da) Biparatopiske anti-her2-antistof-lægemiddelkonjugater og anvendelsesfremgangsmåder
EP3324894A4 (en) LATERAL AND MEDIAL SWITCHING KNEE PROSTHESIS
HUE053616T2 (hu) Anti-SEZ6 antitest-hatóanyag konjugátumok és alkalmazási eljárások
DK3652145T3 (da) Krystallinsk form af triethylentetramintetrahydrochlorid og farmaceutisk anvendelse deraf
EP3595670A4 (en) MEDICINAL-POLYMER CONJUGATE
EP3773654A4 (en) PHARMACEUTICAL COMPOSITIONS OF THE ACTIVE SUBSTANCE AND RELATED PROCEDURES
IL282157A (en) Compounds and therapeutic uses thereof